These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8094722)

  • 21. Cardiovascular and antiarrhythmic effects of esmolol in children.
    Trippel DL; Wiest DB; Gillette PC
    J Pediatr; 1991 Jul; 119(1 Pt 1):142-7. PubMed ID: 1676729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
    Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
    Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction.
    Morelli A; Romano SM; Sanfilippo F; Santonocito C; Frati G; Chiostri M; Agrò FE; Ertmer C; Rehberg SW; Vieillard-Baron A
    Br J Anaesth; 2020 Dec; 125(6):1018-1024. PubMed ID: 32690246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esmolol and left ventricular function in the awake dog.
    Jacobs JR; Maier GW; Rankin JS; Reves JG
    Anesthesiology; 1988 Mar; 68(3):373-8. PubMed ID: 2894187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic pharmacology of esmolol.
    Gorczynski RJ
    Am J Cardiol; 1985 Oct; 56(11):3F-13F. PubMed ID: 2864846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of histamine receptors on basal left ventricular contractile tone in humans: assessment using the H2 receptor antagonist famotidine and the beta-adrenoceptor antagonist esmolol as pharmacologic probes.
    Borow KM; Ehler D; Berlin R; Neumann A
    J Am Coll Cardiol; 1992 May; 19(6):1229-36. PubMed ID: 1348751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left Ventricle Function During Therapeutic Hypothermia with Beta
    Bergan HA; Halvorsen PS; Espinoza A; Kerans V; Skulstad H; Fosse E; Bugge JF
    Ther Hypothermia Temp Manag; 2018 Sep; 8(3):156-164. PubMed ID: 29394143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of esmolol given during cardiopulmonary bypass on fractional area of contraction from transesophageal echocardiography.
    Cork RC; Azari DM; McQueen KA; Aufderheide S; Mitchell M; Naraghi M
    Anesth Analg; 1995 Aug; 81(2):219-24. PubMed ID: 7618705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of esmolol and dexmedetomidine on myocardial oxygen consumption during sympathetic stimulation in dogs.
    Willigers HM; Prinzen FW; Roekaerts PM
    J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):364-70. PubMed ID: 16750737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pacemaker sites on contractile forces of the local myocardium and blood flow in the major branches of the left coronary artery in anesthetized open-chest dogs.
    Saito D; Takeda K; Hyodo T; Abe Y; Tani H; Nagahana H; Uchida T; Haraoka S; Nagashima H
    Jpn Circ J; 1984 Apr; 48(4):331-5. PubMed ID: 6716632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esmolol decreases the adverse effects of acute coronary artery occlusion on myocardial metabolism and regional myocardial blood flow in dogs.
    Sidi A; Davis RF
    Anesth Analg; 1988 Feb; 67(2):124-30. PubMed ID: 2829657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic effects of esmolol, an ultrashort-acting beta blocker.
    Askenazi J; MacCosbe PE; Hoff J; Turlapaty P; Hua TA; Laddu A
    J Clin Pharmacol; 1987 Aug; 27(8):567-73. PubMed ID: 2888793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts.
    Ikeshita K; Nishikawa K; Toriyama S; Yamashita T; Tani Y; Yamada T; Asada A
    J Anesth; 2008; 22(4):361-6. PubMed ID: 19011773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of the force-frequency effect on myocardial contractility by adrenergic stimulation in conscious dogs.
    Kambayashi M; Miura T; Oh BH; Rockman HA; Murata K; Ross J
    Circulation; 1992 Aug; 86(2):572-80. PubMed ID: 1353420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.
    Sugiyama A; Takahara A; Hashimoto K
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):70-7. PubMed ID: 10413070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the partial beta 1-adrenergic agonist, xamoterol, on hemodynamics and regional myocardial function during acute coronary occlusion in dogs.
    Miura T; Matsuzaki M; Toma Y; Yonezawa F; Kohno M; Katayama K; Ozaki M; Kumada T; Kusukawa R
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):182-7. PubMed ID: 1689411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
    Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
    J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of severity of coronary artery disease for the tolerance to normovolemic hemodilution. Comparison of single-vessel versus multivessel stenoses in a canine model.
    Spahn DR; Smith LR; Schell RM; Hoffman RD; Gillespie R; Leone BJ
    J Thorac Cardiovasc Surg; 1994 Aug; 108(2):231-9. PubMed ID: 8041171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of esmolol in whole-body hyperthermia: cardiovascular effects.
    Berry JM; Michalsen A; Nagle V; Bull JM
    Int J Hyperthermia; 1997; 13(3):261-8. PubMed ID: 9222810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology and pharmacokinetics of esmolol.
    Reynolds RD; Gorczynski RJ; Quon CY
    J Clin Pharmacol; 1986 Mar; 26(S1):A3-A14. PubMed ID: 2870084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.